- funding probability score
- total disclosed funding
- last round valuation estimate
- disclosed funding rounds
- latest round
- latest funding stage
- next round estimate
- development stage
- number of investors
- number of competitors
- monthly web visits
- twitter followers
- Amblyotech is the developer of novel electronic media therapies designed for the treatment of Amblyopia and other ocular diseases and conditions in adults and children.
Amblyotech has developed a revolutionary treatment to cure Amblyopia without the need of current treatment options, including patching, atropine drops, and surgery. The current treatment options do not address the Dichoptic clinical need. Their product establishes the cooperation between the two eyes, which results in greater clinical efficacy. Those affected by Amblyopia will obtain a binocular solution with the establishment of 3D vision.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats